share_log

Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

SEC ·  Aug 11, 2023 19:17
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.